Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM74A6 denotes a human gene classified as a long non-coding RNA (lncRNA), meaning it is not expected to encode a functional protein product. No evidence currently indicates that FAM74A6 acts as a receptor, enzyme, transporter, or conventional therapeutic target[3]. Its molecular function, role in physiological or pathological processes, and potential as a drug target have not been described in the scientific literature or established gene/protein databases. There is no evidence that "FAM74A6" is a functional receptor, enzyme, or protein, nor that it has direct therapeutic relevance or established disease associations[3]. The actual function of FAM74A6 remains uncharacterized, and it is not classified under any known protein family with druggable or targetable activity[3]. The main issue is that FAM74A6 is not a conventional drug target gene or protein, and may be included due to confusion with similarly named but functionally distinct "FAM" family members.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 74 member A6 (FAM74A6).